Zanamivir

(公費)Relenza

(公費)瑞樂沙

5mg/cap, 20cap/box

03. ANTIMICROBIALS; ;

03.09. ANTI-INFLUENZAS;;

Antiviral Agent; Neuraminidase Inhibitor

治療流行性感冒

X 動物或人體的試驗中或使用經驗發現對胎兒有害，而造成的傷害明顯大於可能的益處。

Unknown

Inhalation
Treatment: Two inhalations (10 mg) twice daily for 5 days. Doses on first day should be separated by at least 2 hours; on subsequent days, doses should be spaced by ~12 hours. Begin within 2 days of signs or symptoms. Longer treatment may be considered for patients who remain severely ill after 5 days
Prophylaxis (household exposure): Two inhalations (10 mg) once daily for 7 days after last known exposure
Prophylaxis (institutional outbreak): Two inhalations (10 mg) once daily; continue for ≥2 weeks and until ~7 days after identification of illness onset in the last patient
Prophylaxis (community outbreak): Two inhalations (10 mg) once daily; continue until influenza activity in community subsides or immunity obtained from immunization; up to 28 days has been well tolerated

Headache, sore throat, nasal signs and symptoms, tonsil disease

1.本品含乳糖
2.藥品裝上吸入裝置前不可刺破任何一個泡殼
3.每盒有5片，每片含有4個規則間隔的雙面錫箔泡囊

建立者

103617

建立時間

2019-11-13 11:10:57

維護者

103617

維護時間

2019-11-13 11:31:22